<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Regenerative Therapy</title>
	<link>http://mynewtherapy.com</link>
	<description>Clinical Guide to Stem Cells &#38; Regenerative Medicine</description>
	<lastBuildDate>Tue, 15 May 2012 14:37:35 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.0.1" -->

	<item>
		<title>Cartilage Repair &#8211; Tissue Implant</title>
		<description><![CDATA[Regenerative medicine company Histogenics Corporation, announced today the presentation of intermediate term data supporting the clinical efficacy of the Company&#8217;s NeoCart Autologous Cartilage Tissue Implant (ACTI) for periods of up to five years with no evidence of severe treatment-related adverse events in patients with grade III chondral injury to the femur (cartilage damage in the knee).
NeoCart® is an implant grown ex vivo (outside the body) from the patient’s own cartilage cells.
NeoCart recently entered a Phase ...]]></description>
		<link>http://mynewtherapy.com/cartilage-tissue-implant/</link>
			</item>
	<item>
		<title>Embryonic versus adult stem cells</title>
		<description><![CDATA[Embryonic versus adult stem cells &#8211; Illustrated explanations
http://www.youtube.com/watch?v=3Axkn8G18t8&#38;feature=related

]]></description>
		<link>http://mynewtherapy.com/embryonic-versus-adult-stem-cells-2/</link>
			</item>
	<item>
		<title>Cancer Immunotherapy</title>
		<description><![CDATA[Tumor Immunology and Immunotherapy
Nature Reviews Issue dedicated entierly to the subject.
http://www.nature.com/reviews/focus/tumourimmunology/index.html
]]></description>
		<link>http://mynewtherapy.com/cancer-immunotherapy/</link>
			</item>
	<item>
		<title>Disc Repair Phase 2 Trial Update</title>
		<description><![CDATA[Report on intermediate results of clinical study:
The publication showed that a single non-surgical injection of Mesoblast’s allogeneic mesenchymal progenitor cells (MPCs) into damaged intervertebral discs resulted in significant regeneration of disc anatomy, increase in proteoglycan content, and increase in disc height, for at least six months.
Published in:
Journal of Neurosurgery, Posted online on March 9, 2012
Entitled “Immunoselected STRO-3+mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs”, can be viewed at:
http://thejns.org/doi/full/10.3171/2012.1.SPINE11852
Mesoblast, Australia
]]></description>
		<link>http://mynewtherapy.com/disc-repair-phase-2-trial-update/</link>
			</item>
	<item>
		<title>Limb Ischemia treatment with mesenchymal stem cells</title>
		<description><![CDATA[ Paper title:
&#8220;Cellular Therapy With Ixmyelocel-T to Treat Critical Limb Ischemia: The Randomized, Double-blind, Placebo-controlled RESTORE-CLI Trial&#8221;
Richard J Powell et al. Molecular Therapy ( April 2012)
From the abstract:
&#8220;Ixmyelocel-T is a patient-specific, expanded, multicellular therapy evaluated in patients with lower extremity critical limb ischemia (CLI) with no options for revascularization. This randomized, double-blind, placebo-controlled, phase 2 trial (RESTORE-CLI) compared the efficacy and safety of intramuscular injections of ixmyelocel-T with placebo. 
&#8220; Ixmyelocel-T treatment was well tolerated and may offer ...]]></description>
		<link>http://mynewtherapy.com/limb-ischemia-treatment-with-mesenchymal-stem-cells/</link>
			</item>
	<item>
		<title>Immunotherapy of Melanoma</title>
		<description><![CDATA[A new review article on adoptive immunotherapy by Steve Rosenberg:
Sci Transl Med. 2012 Mar 28;4(127):
&#8220;Raising the bar: the curative potential of human cancer immunotherapy&#8221;.
PubMed:  http://www.ncbi.nlm.nih.gov/pubmed/22461638


Abstract
&#8220;Immunotherapy with interleukin-2 can cure 5 to 10% of patients with metastatic melanoma and renal cancer. Recent adoptive cell transfer (ACT) immunotherapies have improved cure rates in metastatic melanoma to 20 to 40%. Genetic engineering of T cells to express conventional alpha/beta T cell receptors or antibody-based chimeric antigen receptors provides ...]]></description>
		<link>http://mynewtherapy.com/immunotherapy-of-melanoma/</link>
			</item>
	<item>
		<title>ALS treatment with neural stem cells</title>
		<description><![CDATA[Title:
Lumbar Intraspinal Injection of Neural Stem Cells in Patients with ALS: Results of a Phase I Trial in 12 Patients.
Glass JD, et al  Stem Cells. 2012 Mar 13. [Epub ahead of print]
Abstract:
http://www.ncbi.nlm.nih.gov/pubmed/22415942.1
Phase I safety trial of intraspinal injections of fetal-derived neural stems cells in patients with Amyotrophic Lateral Sclerosis (ALS).
Emory University School of Medicine, Atlanta, GA USA
]]></description>
		<link>http://mynewtherapy.com/als-treatment-with-neural-stem-cells/</link>
			</item>
	<item>
		<title>Breast reconstruction surgery by stem cells</title>
		<description><![CDATA[CYTORI BREAST RECONSTRUCTION CELL THERAPY TRIAL RESULTS PUBLISHED
http://ir.cytori.com/InvestorRelations/releasedetail.cfm?ReleaseID=657974
Published in:
&#8220;Prospective trial of Adipose-Derived Regenerative Cell (ADRC)-enriched fat grafting for partial mastectomy defects: The RESTORE-2 trial&#8221;
R. Pérez-Canoa, J.J. Vranckxb, J.M. Lassoa, C. Calabresec, B. Merckd, A.M. Milsteine, E. Sassoonf, E. Delayg, E.M. Weiler-Mithoffh,
European Journal of Surgical Oncology &#8211; March 2012
]]></description>
		<link>http://mynewtherapy.com/breast-reconstruction-surgery-by-stem-cells/</link>
			</item>
	<item>
		<title>Ischemic stroke treatment with stem cells</title>
		<description><![CDATA[A phase I/II clinical study using modified  non related stem cells for treating stable ischemic stroke.
Recruiting patients April 2011
http://clinicaltrials.gov/ct2/show/NCT01287936?term=Stanford%2C+SanBio&#38;rank=1
Performed in Stanford University School of Medicine, CA US.
Sponsored by SanBio Inc. http://www.san-bio.com/
March 2012
SanBio Announces Enrollment of First Cohort of Patients in Its Clinical Trial of Stem Cell Therapy for Chronic Stroke
http://www.san-bio.com/news/documents/SanBio_First_Cohort_2012.03.20.pdf
]]></description>
		<link>http://mynewtherapy.com/ischemic-stroke-treatment-with-stem-cells/</link>
			</item>
	<item>
		<title>Kidney transplant facilitated by stem cells</title>
		<description><![CDATA[Abstract:
Title: &#8220;Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation.&#8221;
Induction of immune tolerence by organ donor hematopoietic stem cells enables kidney transplant following immune suppression.
&#8220;These results suggest that manipulation of a mobilized stem cell graft and nonmyeloablative conditioning represents a safe, practical, and reproducible means of inducing durable chimerism and donor-specific tolerance in solid organ transplant recipients.&#8221;
Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud ...]]></description>
		<link>http://mynewtherapy.com/kidney-transplant-facilitated-by-stem-cells/</link>
			</item>
</channel>
</rss>

